| Lenalidomide which is a novel immunomodulatory agent,has the characteristics of immune regulation and anti-tumor.A lot of researchs at rescent years have suggested that it has a good efficacy and safety in the treatment of multiple myeloma,leukemia,lymphoma,myelodysplastic syndrome and so on.This article tries will review the research progress of lenalidomide in hematological malignancies. |
PDF Full Text Request